CCNG1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.000970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.692000E-01
Normal-vs-Stage2
1.046420E-01
Normal-vs-Stage3
1.172370E-02
Normal-vs-Stage4
4.599400E-01
Stage1-vs-Stage2
6.296000E-01
Stage1-vs-Stage3
3.071600E-01
Stage1-vs-Stage4
8.907000E-01
Stage2-vs-Stage3
1.630350E-01
Stage2-vs-Stage4
2.666800E-01
Stage3-vs-Stage4
2.517600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.014000E-01
Normal-vs-AfricanAmerican
3.273000E-01
Normal-vs-Asian
8.139800E-02
Caucasian-vs-AfricanAmerican
6.357800E-01
Caucasian-vs-Asian
4.153800E-01
AfricanAmerican-vs-Asian
4.200400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.621700E-02
Normal-vs-Female
1.282200E-01
Male-vs-Female
9.217400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.517900E-02
Normal-vs-Age(41-60Yrs)
1.779640E-01
Normal-vs-Age(61-80Yrs)
6.062400E-02
Normal-vs-Age(81-100Yrs)
4.054800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.451200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.791200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.405400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.713600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.533600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.762200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.739900E-02
Normal-vs-Daily Drinker
4.380400E-02
Normal-vs-Weekly Drinker
8.634100E-02
Normal-vs-Occasional Drinker
6.469700E-02
Normal-vs-Social Drinker
1.999000E-01
Non Drinker-vs-Daily Drinker
1.256550E-01
Non Drinker-vs-Weekly Drinker
4.418000E-01
Non Drinker-vs-Occasional Drinker
4.902200E-01
Non Drinker-vs-Social Drinker
2.693000E-01
Daily Drinker-vs-Weekly Drinker
6.231800E-01
Daily Drinker-vs-Occasional Drinker
4.935000E-01
Daily Drinker-vs-Social Drinker
4.421800E-02
Weekly Drinker-vs-Occasional Drinker
9.032600E-01
Weekly Drinker-vs-Social Drinker
1.636230E-01
Occasional Drinker-vs-Social Drinker
1.552590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.039900E-02
Normal-vs-Grade 2
8.922900E-03
Normal-vs-Grade 3
9.019900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.357900E-02
Grade 1-vs-Grade 3
5.793800E-02
Grade 1-vs-Grade 4
4.039900E-02
Grade 2-vs-Grade 3
7.521000E-01
Grade 2-vs-Grade 4
8.922900E-03
Grade 3-vs-Grade 4
9.019900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.112800E-01
Normal-vs-NonDiabetic
3.295900E-02
Diabetic-vs-NonDiabetic
4.642200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.719600E-02
Normal-vs-NoPancreatitis
5.313600E-02
Pancreatitis-vs-NoPancreatitis
2.731000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.893970E-01
Normal-vs-N1
7.306200E-02
N0-vs-N1
8.622400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.584040E-01
Normal-vs-TP53-NonMutant
5.613200E-01
TP53-Mutant-vs-TP53-NonMutant
2.446400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
